Skip to content
Cash Flow Statement · TASI 8040

Mutakamela Insurance Co.
Cash and cash equivalents at period end · Shareholders’ operations history.

Cash and cash equivalents at the end of each reporting period. Figures apply to shareholders’ operations. Explore 18 reported observations from 2018 to 2022, with every value linked to its official evidence.

Coverage2018–202218 source-linked periods
Annual history3annual reporting periods
Interim history15quarterly or year-to-date periods
StatementCash Flow Statementas reported by the issuer
Annual series

Cash and cash equivalents at period end · Shareholders’ operations

The series uses the same reporting duration and currency. The filing values appear below.

2020IFRS 4Cash and cash equivalents at period end · Shareholders’ operations137.41M SAR
Cash and cash equivalents at period end · Shareholders’ operations050M100M150M201820192020
Hover or tap to exploreSAR
First-quarter series

Cash and cash equivalents at period end · Shareholders’ operations

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Cash and cash equivalents at period end · Shareholders’ operations84.32M SAR
Cash and cash equivalents at period end · Shareholders’ operations050M100M150M200M20182019202020212022
Hover or tap to exploreSAR
Half-year series

Cash and cash equivalents at period end · Shareholders’ operations

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Cash and cash equivalents at period end · Shareholders’ operations108.86M SAR
Cash and cash equivalents at period end · Shareholders’ operations050M100M150M20182019202020212022
Hover or tap to exploreSAR
Nine-month series

Cash and cash equivalents at period end · Shareholders’ operations

The series uses the same reporting duration and currency. The filing values appear below.

2022IFRS 4Cash and cash equivalents at period end · Shareholders’ operations39.82M SAR
Cash and cash equivalents at period end · Shareholders’ operations050M100M150M20182019202020212022
Hover or tap to exploreSAR
Official evidence ledger

Every value, period and source.

Normalized values support comparison. The reported value and unit preserve the original filing presentation.

PeriodReported valueComparable valueReported lineEvidence
9M / Q3 20222022-09-3039,816,7932022-01-01 to 2022-09-3039.82M SARCash and cash equivalents at end of periodNote 4Official p. 8 ↗Open statement →
H1 / Q2 20222022-06-30108,861,9022022-01-01 to 2022-06-30108.86M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
Q1 20222022-03-3184,320,1822022-01-01 to 2022-03-3184.32M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
9M / Q3 20212021-09-30128,293,9422021-01-01 to 2021-09-30128.29M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
H1 / Q2 20212021-06-30143,248,5462021-01-01 to 2021-06-30143.25M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
Q1 20212021-03-31155,042,1982021-01-01 to 2021-03-31155.04M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
FY 20202020-12-31137,406,6672020-01-01 to 2020-12-31137.41M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
9M / Q3 20202020-09-30115,782,0452020-01-01 to 2020-09-30115.78M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
H1 / Q2 20202020-06-3041,485,8862020-01-01 to 2020-06-3041.49M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
Q1 20202020-03-3129,690,3072020-01-01 to 2020-03-3129.69M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
FY 20192019-12-3161,819,1912019-01-01 to 2019-12-3161.82M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
9M / Q3 20192019-09-30119,699,1322019-01-01 to 2019-09-30119.7M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
H1 / Q2 20192019-06-30107,501,5502019-01-01 to 2019-06-30107.5M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
Q1 20192019-03-3121,106,3992019-01-01 to 2019-03-3121.11M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
FY 20182018-12-3145,412,0352018-01-01 to 2018-12-3145.41M SARCash and cash equivalents at end of periodNote 4Official p. 44 ↗Open statement →
9M / Q3 20182018-09-3017,130,4812018-01-01 to 2018-09-3017.13M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
H1 / Q2 20182018-06-304,742,8882018-01-01 to 2018-06-304.74M SARCash and cash equivalents at end of periodOfficial source ↗Open statement →
Q1 20182018-03-311,784,5082018-01-01 to 2018-03-311.78M SARCash and cash equivalents at end of periodNote 4Official source ↗Open statement →
How to read this series

Reported first. Comparable second.

We show the original label and figure alongside its normalized value. Annual, first-quarter, half-year and nine-month series are separate. Per-share figures keep the issuer’s reported share basis.

سجل مالي موثق بالمصدر

متكاملة — Cash and cash equivalents at period end · Shareholders’ operations

تُعرض القيم كما وردت في القوائم المالية الرسمية، مع فصل الفترات السنوية والمرحلية وربط كل قيمة بصفحة المصدر الرسمي. تُعرض ربحية السهم وفق أساس الأسهم الوارد في كل تقرير.